Saturday, July 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Asian Markets

TSMC Wins Approval for $44 Billion Arizona Buildout as AI Boom Powers Pricing Power

SiterGedge by SiterGedge
July 4, 2026
in Asian Markets, Semiconductors, Tech & Software
0
TSMC Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Taiwan’s Ministry of Economic Affairs has cleared a fresh $20 billion investment by TSMC into its Arizona operations, bringing the total authorized outlay for the US project to $44 billion. The decision, announced Thursday by the ministry’s Investment Review division, marks the sixth such green light for the chipmaker’s American expansion. Yet the island’s economy minister was quick to underline that the US will not overtake Taiwan’s production capacity — TSMC plans 16 fabs and state-of-the-art chip-on-wafer-on-substrate packaging plants at home, keeping the heart of its manufacturing firmly in Asia.

The new capital will be directed toward a 12-inch wafer fabrication plant and an advanced packaging facility in Arizona. TSMC is racing to build capacity outside its home base in response to surging demand for artificial intelligence hardware, but the ministry’s message was clear: Washington’s push to strengthen domestic chipmaking will not diminish Taiwan’s strategic importance for the foreseeable future.

Investors welcomed the news, sending the stock up 4.21% on Friday to close at €396.00. The shares now sit less than 6% below their 52-week high of €420.50, reached on July 1, and have nearly doubled over the past twelve months. Year-to-date, the gain stands at 45.05%, while the stock trades 36.70% above its 200-day moving average — a clear signal of the steep uptrend in recent months. Chart watchers point to the 50-day line at €363.12 as a key support that, if held, would keep the rally intact.

Should investors sell immediately? Or is it worth buying TSMC?

The growth engine is unmistakable: artificial intelligence. Some 74% of TSMC’s revenue now comes from chips built on 7-nanometer nodes or smaller. With an estimated 75% share of the global foundry market, the company wields enormous pricing power, and market reports indicate it plans to raise prices on advanced nodes by 5% to 10%. That leverage is feeding through to earnings expectations: analysts see EPS climbing by nearly half to $15.80, while capital expenditure for 2026 is projected to reach $56 billion to keep pace with the AI buildout.

Competitive pressure is building, however. Rumors have surfaced that Meta could shift some orders for new AI chips to Samsung, which is positioning its 2-nanometer process as a rival. Apple, for its part, remains loyal to TSMC. Investment bank Goldman Sachs notes that hedge funds continue to overweight AI beneficiaries, with TSMC at the center of that megatrend.

Management’s outlook for the second quarter of 2026 calls for revenue between $39 billion and $40.2 billion, with an operating margin of 56.5% to 58.5%. While the overseas expansion and the development of 2-nanometer technology could temporarily pressure gross margins, the longer-term rationale is to reduce geopolitical risk and secure TSMC’s technological lead. For now, the market is betting that the pricing power and AI tailwind will more than compensate.

Ad

TSMC Stock: Buy or Sell?! New TSMC Analysis from July 4 delivers the answer:

The latest TSMC figures speak for themselves: Urgent action needed for TSMC investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 4.

TSMC: Buy or sell? Read more here...

Tags: TSMC
SiterGedge

SiterGedge

Related Posts

Intuit Stock
Analysis

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

July 4, 2026
Realbotix Stock
Mergers & Acquisitions

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

July 4, 2026
Lam Research Stock
Nasdaq

Lam Research’s Whiplash Week: Record High, Insider Sales, and a $600 Million China Question

July 4, 2026
Next Post
Onco-Innovations Stock

Onco-Innovations’ Share-Linked Payment Plan Threatens Dilution Even as Nanosoft Boosts ONC010 Manufacturing

ImmunityBio Stock

ImmunityBio's 369% Surge Meets 13% Short Interest — A Collision Course in Biotech

Lam Research Stock

Lam Research’s Whiplash Week: Record High, Insider Sales, and a $600 Million China Question

Recommended

Ford Stock

Ford’s Strategic Pivot Under Investor Scrutiny Ahead of Earnings

5 months ago
Procter & Gamble Stock

Procter & Gamble: A Defensive Haven in Turbulent Markets

10 months ago
Finances (2)

Stifel Analyst Reaffirms Buy Rating and Raises Price Target for Align Technology

2 years ago
Rocket Lab USA Stock

Strategic Expansion and Record Contracts Fuel Rocket Lab’s Momentum

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

Lam Research’s Whiplash Week: Record High, Insider Sales, and a $600 Million China Question

ImmunityBio’s 369% Surge Meets 13% Short Interest — A Collision Course in Biotech

Onco-Innovations’ Share-Linked Payment Plan Threatens Dilution Even as Nanosoft Boosts ONC010 Manufacturing

TSMC Wins Approval for $44 Billion Arizona Buildout as AI Boom Powers Pricing Power

Trending

Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

by Rodolfo Hanigan
July 4, 2026
0

July is shaping up as a binary-riddled month for the small-cap biopharma. Two weeks after shareholders cast...

SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

July 4, 2026
Mercedes-Benz Stock

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

July 4, 2026
Intuit Stock

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

July 4, 2026
Realbotix Stock

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

July 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010
  • Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads
  • Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com